A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of antipsychotic treatment, among individuals ages 5-24 years.
U.S. Suspends Wuhan Lab Funding; ‘Zombie’ Clinical Trials; Wachter’s COVID Scare
Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. U.S. Suspends Wuhan Lab’s Funding The